Innoviva Inc (INVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | INVA | AMGN | GILD | CELG | BIIB |
| Company | Innoviva Inc | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Biogen Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 15.01 | 265.72 | 65.50 | 108.01 | 201.22 |
| High | 15.29 | 271.68 | 66.35 | 108.59 | 210.83 |
| Low | 14.98 | 265.72 | 64.63 | 107.27 | 199.10 |
| Last | 15.26 | 269.98 | 65.42 | 108.24 | 208.90 |
| Change | +0.27 | +0.60 | +0.15 | +0.11 | +6.44 |
| % Change | +1.80% | +0.22% | +0.23% | +0.10% | +3.18% |
| Volume | 283,991 | 2,329,531 | 12,322,693 | 191,230,496 | 1,870,183 |
| 20-Day Average Volume | 627,438 | 2,096,692 | 6,927,986 | 16,188,930 | 1,257,310 |
| Previous Close | 14.99 | 269.38 | 65.27 | 108.13 | 202.46 |
| Industry | Large Cap Pharma | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 14.80 | 270.04 | 68.30 | 108.17 | 201.17 |
| 20-Day Raw Stochastic | 91.18% | 44.38% | 10.07% | 63.25% | 77.54% |
| 20-Day Relative Strength | 55.48% | 46.55% | 29.65% | 64.69% | 50.56% |
| Weighted Alpha | +26.17 | +10.02 | -23.36 | +46.30 | -31.24 |
| Today's Opinion | 40% Buy | 56% Sell | 100% Sell | 100% Buy | 80% Sell |
| Previous Opinion | 16% Buy | 72% Sell | 100% Sell | 100% Buy | 88% Sell |
| Last Month's Opinion | 40% Buy | 40% Buy | 88% Sell | 100% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.04% since 04/19/24 | +0.77% since 04/19/24 | -1.89% since 04/19/24 | -1.97% since 11/13/19 | +7.93% since 04/19/24 |
| Low | 14.83 on 04/22/24 | 265.72 on 04/26/24 | 64.63 on 04/26/24 | 107.27 on 11/20/19 | 192.75 on 04/23/24 |
| High | 15.35 on 04/23/24 | 274.86 on 04/24/24 | 67.90 on 04/25/24 | 110.53 on 11/14/19 | 210.83 on 04/26/24 |
| 1-Month | |||||
| %Chg | +1.84% since 03/26/24 | -3.83% since 03/26/24 | -9.55% since 03/26/24 | +5.14% since 10/18/19 | -1.05% since 03/26/24 |
| Low | 14.32 on 04/16/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 102.40 on 10/21/19 | 189.44 on 04/19/24 |
| High | 15.39 on 03/28/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 110.70 on 11/13/19 | 217.57 on 03/28/24 |
| 3-Month | |||||
| %Chg | -7.26% since 01/26/24 | -13.08% since 01/26/24 | -17.64% since 01/26/24 | +13.63% since 08/20/19 | -14.31% since 01/26/24 |
| Low | 14.32 on 04/16/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 93.41 on 08/23/19 | 189.44 on 04/19/24 |
| High | 16.76 on 01/29/24 | 329.72 on 02/05/24 | 80.00 on 01/29/24 | 110.70 on 11/13/19 | 251.99 on 01/31/24 |
| 6-Month | |||||
| %Chg | +21.46% since 10/26/23 | +0.47% since 10/26/23 | -16.57% since 10/26/23 | +14.14% since 05/20/19 | -12.98% since 10/26/23 |
| Low | 12.22 on 11/01/23 | 249.70 on 10/31/23 | 64.63 on 04/26/24 | 89.08 on 07/23/19 | 189.44 on 04/19/24 |
| High | 16.86 on 01/04/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 268.30 on 01/03/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 947,773 | 144,488,960 | 81,266,176 | 77,035,920 | 29,429,788 |
| Shares Outstanding, K | 63,227 | 536,376 | 1,245,077 | 711,714 | 145,361 |
| Annual Sales | 310,460,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 9,835,600,000 |
| Annual Net Income | 179,720,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | 1,161,100,000 |
| Last Quarter Sales | 85,840,000 | 8,196,000,000 | 7,114,000,000 | 4,520,000,000 | 2,386,300,000 |
| Last Quarter Net Income | 61,530,000 | 767,000,000 | 1,429,000,000 | 1,691,000,000 | 249,700,000 |
| 60-Month Beta | 0.57 | 0.58 | 0.19 | 1.41 | -0.02 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.76 on 02/29/24 | 4.71 on 02/06/24 | -1.32 on 04/25/24 | 2.99 on 10/31/19 | 3.67 on 04/24/24 |
| Latest Earnings Date | 05/14/24 | 05/02/24 | 04/25/24 | 10/31/19 | 04/24/24 |
| Most Recent Dividend | 0.250 on 09/08/15 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | 09/08/15 | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 6.77 | 14.64 | 9.98 | 10.99 | 13.47 |